medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 2

<< Back Next >>

Med Int Mex 2018; 34 (2)

Lyme disease acquired at Morelos, Mexico

García Frade-Ruiz LF
Full text How to cite this article

Language: Spanish
References: 12
Page: 342-348
PDF size: 398.97 Kb.


Key words:

Lyme disease, Tick bite.

ABSTRACT

We present the case of a patient who referred tick bite 18 months previous in legs and neck during the stay in Tequesquitengo, Morelos state, continuing the following months with fatigue, dizziness, muscle aches, arthritis, weight loss and alterations in recent memory. Differential diagnoses and Western blotting were performed for B. burgdorferi, which established the diagnosis of late manifestations of Lyme disease. Lyme disease is a zoonosis transmitted by Ixodes ticks and occurs in approximately 300,000 cases annually in the United States. The most frequent clinical manifestation in the early form is the erythema migrans, being able to present neurological and cardiac manifestations. It is possible that multifactorial phenomena, such as climate changes, favor the extension of this zoonosis outside the traditional territory of North America. We must take into account in our clinical practice the manifestations of Lyme disease for its timely diagnosis and treatment, regardless of its geographical incidence.


REFERENCES

  1. Shapiro E. Lyme disease. N Engl J Med 2014;370:1724-31.

  2. Wormser G. Early Lyme disease. N Engl J Med 2006;354:2794-801.

  3. Feder H, Johnson B, O’Connell S, et al. A critical appraisal of “chronic Lyme disease”. N Engl J Med 2007;357:1422-30.

  4. Berende A, Hofstede H, Vos F, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med 2016;374:1209-20.

  5. Nadelman R, Haninková K, Mukherjee P, et al. Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med 2012;367:1883-90.

  6. Plotkin S. Need for a new Lyme disease vaccine. N Engl J Med 2016 DOI: 10.1056/NEJMp1607146.

  7. Hofhuis A, Kassteele J, Sprong H. Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model. Plos One 2017;12(7):e0181807.

  8. Puri B, Hakkarainen S, Monro J. The effect of artesunate on short-term memory in Lyme borreliosis. Med Hypotheses 2017;105:4-5.

  9. García M, Skinner C, Salas J. Enfermedad de Lyme: actualizaciones. Gac Méd Méx 2014;150:84-95.

  10. Gordillo M, Solórzano F. Enfermedad de Lyme. Experiencia en niños mexicanos. Bol Med Hosp Infant Mex 2010.

  11. Skinner C, Flores M, Esquivel J, et al. Evidencia de la enfermedad de Lyme en una población de alto riesgo del noreste de México. Medicina Universitaria 2007;9(36):105-11.

  12. Gordillo G, Torres J, Solórzano F, et al. Estudio seroepidemiológico de borreliosis de Lyme en la Ciudad de México y el noreste de la República Mexicana. Salud Púb Méx 2003:45(5).




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2018;34